SMSRC Consulting Projects

Strategic intelligence that transforms pharmaceutical businesses.

Specially requisitioned strategic management consulting projects for pharmaceutical companies

SMSRC Consulting Projects are designed to deliver focused, Rx data-driven strategic interventions across three core areas:

Marketing Strategy Assessment & Formulation : Leveraging SPR Rx data to assess and build effective marketing strategies at the company, portfolio, or brand level.

Sales Structure Evaluation : Systematic assessment and formulation of sales structure and key performance parameters to ensure effective execution of marketing strategies.

StratEx: Strategic Execution Reviews : Bi-monthly reviews to monitor and ensure effective on-ground strategic execution and course correction where needed.

SMSRC Consulting Projects are specially commissioned engagements that help pharmaceutical companies navigate complex business challenges, including:

Division, portfolio, or company restructuring to improve sales and profit performance.
Pre-merger evaluation and/or post-merger integration of companies, portfolios, or brands.
Creating strategic space and go-to-market plans for new brand launches.
Restructuring and growth strategy for private equity-backed pharma investments.

With 100+ consulting projects completed, SMSRC has been a trusted strategic partner across the majority of key events in the Indian Pharmaceutical Market (IPM).

SMSRC has led strategic consulting engagements for some of India’s most significant pharmaceutical milestones:

Abbott’s acquisition of Piramal Healthcare
Sun Pharma’s acquisition of Ranbaxy
Torrent’s acquisition of Unichem
Dr. Reddy’s Laboratories’ acquisition of the Wockhardt portfolio
Corporate restructuring of 80% of the Top 20 Pharma Companies in India
Go-to-market strategy for the majority of PE-backed pharma company investments in India since 2009
Restructuring of multiple medium and small pharmaceutical companies